References
- de Dombal F T, Watts J M, Watkinson G, Goligher J C. Local complications of ulcerative colitis: stricture, pseudopolyposis and carcinoma of colon and rectum. Br Med J 1966; 1: 1442–7
- Prior P, Gyde S N, Macartney J C, Thompson H, Waterhouse J AH, Allan R N. Cancer morbidity in ulcerative colitis. Gut 1982; 23: 490–497
- Lennard-Jones J E, Morson B C, Ritchie J K, Shove D C, Williams C B. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology 1977; 73: 1280–9
- Ekbom A, Helmick C, Zack M, Adami H-O. Ulcerative colitis and colorectal cancer, a population based study. N Engl J Med 1990; 323: 1228–33
- Granqvist S, Gabrielsson N, Sundelin P, Thorgeirsson T. Precancerous lesions in the mucosa in ulcerative colitis. Scand J Gastroenterol 1980; 15: 289–96
- Lennard-Jones J E, Morson B C, Ritchie J K, Williams C B. Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet 1983; 2: 149–52
- Rosenstock E, Farmer R G, Petras R, Sivak M V, Rankin G B, Sullivan B H. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985; 89: 1342–6
- Connell W R, Lennard-Jones J E, Williams C B, Talbot I C, Price A B, Wilkinson K H. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107: 934–44
- Löfberg R, Broström O, Karlén P, Tribukait B, Öst Å. Colonoscopic surveillance in long-standing total ulcerative colitis. A 15-year follow-up study. Gastroenterology 1990; 99: 1021–31
- Broomé U, Lindberg G, Löfberg R. Primary sclerosing cholangitis in ulcerative colitis—a risk factor for the development of dysplasia and DNA aneuploidy. Gastroenterology 1992; 102: 1877–80
- Riddel R H, Goldman H, Ransohoff D F, Appelman H D, Fenoglio C M, Haggitt R C, et al. Dysplasia in inflammatory bowel disease: standardised classification with provisional clinical applications. Hum Pathol 1983; 14: 931–68
- Peto R, Pike M C, Amitage N E, Smith P G, Breslow N E, Cox D R, Howard S V, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1–39
- Hakulinen T, Abeywickrama K. A computer program package for relative survival analysis. Comput Programs Biomed 1985; 19: 197–207
- Morson B C, Pang L SC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967; 8: 423–34
- Lashner A B. Recommendations for colorectal cancer screening in ulcerative colitis: a review of research from a single university-based surveillance program. Am J Gastroenterol 1992; 87: 168–75
- Dixon M F, Brown L JR, Gilmour H M, Price A B, Smeeton N C, Talbot I C, et al. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988; 13: 385–97
- Melville D M, Jass J R, Morson B C, Pollock D J, Richman P I, Shepherd N A, et al. Observer study of grading of dysplasia in ulcerative colitis comparison with clinical outcome. Hum Pathol 1989; 20: 1008–14
- Bernstein C, Shanahan F, Weinstein W M. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis. Lancet 1994; 343: 71–4
- Lynch D A, Lobo A J, Sobala G M, Dixon M F, Axon A T. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993; 34: 1075–80
- Biasco G, Brandi G, Paganelli G M, Rossini F P, Santucci R, Di Febo G. Colorectal cancer in patients with ulcerative colitis. A prospective cohort study in Italy. Cancer 1995; 75: 2045–50
- Sugita A, Sachar D B, Bodian C, Ribeiro M B, Aufses A H, Greenstein A J. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis—cancer interval. Gut 1991; 32: 167–9